Table 1 Baseline characteristics
From: The impact of COVID-19 pandemic on cardiac surgery in Israel
2019 Group N = 173 | 2020 Group N = 108 | p-value | |
|---|---|---|---|
Age (mean ± SD) | 63.5 ± 13.5 | 64 ± 13.7 | 0.765 |
Gender (male) (%) | 128 ± 74 | 69 ± 63.9 | 0.096 |
Height (mean ± SD) | 168.9 ± 17.3 | 166.4 ± 16.2 | 0.251 |
Weight (mean ± SD) | 78.6 ± 16.5 | 80.4 ± 21 | 0.440 |
BMI (mean ± SD) | 41.8 ± 183.5 | 31.4 ± 25.9 | 0.592 |
Obesity (%) | 91 (53) | 54 (61) | 0.287 |
Hypertension (%) | 112 (66) | 61 (71) | 0.501 |
PVD (%) | 14 (8) | 5 (8.2) | 1.000 |
Diabetes (%) | 68 (39) | 40 (46) | 0.370 |
Insulin treatment (%) | 2 (7) | 1 (7.7) | 1.000 |
Hyperlipidemia (%) | 109 (65) | 57 (66) | 0.984 |
Atrial fibrillation (%) | 102 (59) | 52 (58) | 1.000 |
Previous MI (%) | 18 (58) | 10 (77) | 0.399 |
Previous revascularization (%) | 0.087 | ||
None | 28 (90) | 9 (69) | |
PCI | 2 (7) | 4 (31) | |
CABG | 1 (3) | 0 (0) | |
Renal impairment (%) | 12 (7) | 12 (14) | 0.126 |
Baseline creatinine (mean ± SD) | 1.05 ± 0.63 | 1.2 ± 0.95 | 0.160 |
COPD (%) | 14 (8) | 11 (14) | 0.272 |
Prior stroke(%) | 14 (8) | 3 (3) | 0.223 |
Dialysis (%) | 1 (0.6) | 2 (2.3) | 0.552 |
Previous cardiac operation (%) | 3 (10) | 1 (8) | 1.000 |
Pulmonary hypertension (> 60 mmHg) (%) | 0 (0) | 2 (15) | 0.149 |
LVEF (%) (mean ± SD) | 52 ± 13.4 | 52.2 ± 13.6 | 0.903 |
NYHA functional class IV (%) | 4 (2) | 6 (6) | 0.007 |
EuroSCORE (standard) (mean ± SD) | 4.89 ± 2.78 | 5.73 ± 3.56 | 0.086 |
EuroSCORE (logistic) (mean ± SD) | 5.41 ± 7.68 | 7.78 ± 11.47 | 0.098 |